Tumor Cells Can be Inhibited with Enterococcus Faecalis-2001

Enterococcus faecalis 2001 acts as an anti-Tumor and improves immune response, which can suppress the growth of Sarcoma-180 cells completely.

Enterococcus faecalis 2001, a probiotic lactic acid bacterium can inhibit the growth of tumors, reveals a new study.

The research team has used Enterococcus faecalis 2001 as a biological response modifier (BRM).

How to Detect Circulating Tumor Cells
A researcher at Gold Coast’s Bond University suggests that opting for a psychological acupuncture could help reduce food cravings and lose weight.

‘Enterococcus faecalis 2001 can enhance antioxidative activity, improves immune response and completely suppresses the growth of Sarcoma-180 cells.’

From physiological limitation of bacterial preservation in storage and safety, the live E. faecalis 2001 has been heat-treated and the BRM components containing high level of £]-glucan, named EF-2001, were prepared.

The heat-treated EF-2001 has been examined for the antioxidative potential for radical scavenging and anti-tumor activities as well as immune-enhancing response in mice.

Lymphocyte versus polymorphonuclear leukocyte ratio was increased in mice upon treatment with EF-2001. The number of lymphocytes was increased in the EF-2001-treated group.

Self-perpetuating Signaling Circuit can Drive Tumor Cells to Spread
International researchers has identified a self-perpetuating signaling circuit inside connective tissue cells that allows these cells to form a front and a back and propelthemselves in a particular direction over a long period of time.

In the mice bearing two different Ehrlich solid and Sarcoma-180 carcinomas, the treatment with EF-2001 resulted in anti-tumor action.

Tumor-suppressive capacity upon treatment with EF-2001 was significantly increased compared to normal controls.

Tumor Cells Influence Their Environment in Order to Avoid an Immune Response
The immune system becomes suppressed when the degenerated cells cause an inflammatory reaction and influence other blood cells with it.

During the time interval administration of 5 weeks between the priming and secondary administration of EF-2001, the expression and production levels of TNF-£\ were also observed in the EF-2001 administered mice.

Additionally, anti-tumor activity examined with the intravenous administration of EF 2001 with a 34 time intervals was also observed, as the growth of Sarcoma-180 cells was clearly inhibited by the EF-2001.

Protein Helps Tumor Cells Enter the Bloodstream
Generally cancer cells have something that every prisoner longs for, that is a master key that allows them to escape.

From the results, it was suggested that the immune response is enhanced due to antioxidative activity caused by the EF-2001 and anti-tumor activity by NK cells and TNF-£\.

Source-Eurekalert